Mechanisms that regulate naïve B cell proliferation and function are incompletely defined. In this study, we test the hypothesis that naïve B cell expansion, survival and ability to present antigen to T lymphocytes can be directly modulated by Toll-like receptor (TLR) agonists. In the absence of B cell receptor stimulation, CpG oligonucleotide, a TLR9 agonist, was particularly efficient in inducing naïve B cell proliferation and survival. Although the expanded naïve B cells did not mature into CD27+ or IgG+ memory B cells, these cells did differentiate into IgM-secreting cells with increased surface expression of HLA-DR, CD40 and CD80. This was associated with an increased potential for these B cells to activate allogeneic T cells. We propose that the activation and expansion of naïve B cells induced by TLR9 agonists could enhance the potential of these cells to interact with cognate antigens and facilitate cell-mediated immune responses. © 2007 Wiley-VCH Verlag GmbH & Co. KGaA, Weinheim.
CITATION STYLE
Jiang, W., Lederman, M. M., Harding, C. V., Rodriguez, B., Mohner, R. J., & Sieg, S. F. (2007). TLR9 stimulation drives naïve B cells to proliferate and to attain enhanced antigen presenting function. European Journal of Immunology, 37(8), 2205–2213. https://doi.org/10.1002/eji.200636984
Mendeley helps you to discover research relevant for your work.